Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia.
Campomelic dysplasia (CD) is a semilethal skeletal malformation syndrome with or without XY sex reversal. In addition to the multiple mutations found within the sex-determining region Y-related high-mobility group box gene (SOX9) on 17q24.3, several chromosome anomalies (translocations, inversions, and deletions) with breakpoints scattered over 1 Mb upstream of SOX9 have been described. Here, we present a balanced translocation, t(4;17)(q28.3;q24.3), segregating in a family with a mild acampomelic CD with Robin sequence. Both chromosome breakpoints have been identified by fluorescence in situ hybridization and have been sequenced using a somatic cell hybrid. The 17q24.3 breakpoint maps approximately 900 kb upstream of SOX9, which is within the same bacterial artificial chromosome clone as the breakpoints of two other reported patients with mild CD. We also report a prenatal identification of acampomelic CD with male-to-female sex reversal in a fetus with a de novo balanced complex karyotype, 46,XY,t(4;7;8;17)(4qter-->4p15.1::17q25.1-->17qter;7qter-->7p15.3::4p15.1-->4pter;8pter-->8q12.1::7p15.3-->7pter;17pter-->17q25.1::8q12.1-->8qter). Surprisingly, the 17q breakpoint maps approximately 1.3 Mb downstream of SOX9, making this the longest-range position effect found in the field of human genetics and the first report of a patient with CD with the chromosome breakpoint mapping 3' of SOX9. By using the Regulatory Potential score in conjunction with analysis of the rearrangement breakpoints, we identified a candidate upstream cis-regulatory element, SOX9cre1. We provide evidence that this 1.1-kb evolutionarily conserved element and the downstream breakpoint region colocalize with SOX9 in the interphase nucleus, despite being located 1.1 Mb upstream and 1.3 Mb downstream of it, respectively. The potential molecular mechanism responsible for the position effect is discussed.
Velagaleti
Gopalrao V N
GV
Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Bien-Willner
Gabriel A
GA
Northup
Jill K
JK
Lockhart
Lillian H
LH
Hawkins
Judy C
JC
Jalal
Syed M
SM
Withers
Marjorie
M
Lupski
James R
JR
Stankiewicz
Pawel
P
D000015:Abnormalities, Multiple / Q000235:genetics*; D000293:Adolescent; D001483:Base Sequence; D001848:Bone Diseases, Developmental / Q000235:genetics*; D002648:Child; D019457:Chromosome Breakage / Q000235:genetics*; D002886:Chromosomes, Human, Pair 17; D002894:Chromosomes, Human, Pair 4; D012734:Disorders of Sex Development; D005260:Female; D006609:High Mobility Group Proteins / Q000235:genetics*; D006801:Humans; D007231:Infant, Newborn; D008969:Molecular Sequence Data; D055758:SOX9 Transcription Factor; D014157:Transcription Factors / Q000235:genetics*; D014178:Translocation, Genetic
D006609:High Mobility Group Proteins; D055758:SOX9 Transcription Factor; C527932:SOX9 protein, human; D014157:Transcription Factors
Hum Mol Genet. 1998;7(10):1611-8
9735382
Nat Genet. 1999 May;22(1):85-9
10319868
Hum Mol Genet. 1997 Jan;6(1):91-8
9002675
Genome Res. 2004 Apr;14(4):708-15
15060014
Science. 2003 Oct 17;302(5644):413
14563999
Am J Med Genet. 1996 Jun 14;63(3):461-7
8737653
Cell. 1994 Dec 16;79(6):1111-20
8001137
Cell. 2004 Sep 3;118(5):555-66
15339661
Curr Opin Genet Dev. 2004 Jun;14(3):308-15
15172675
Nat Genet. 2002 Dec;32(4):623-6
12426570
Nat Genet. 2005 Jan;37(1):31-40
15608638
Hum Mol Genet. 2002 Jan 1;11(1):33-42
11772997
Am J Hum Genet. 1999 Jul;65(1):111-24
10364523
J Med Genet. 1995 Jun;32(6):415-20
7666392
Hum Mol Genet. 2003 Oct 15;12 Spec No 2:R207-13
12915455
Am J Ophthalmol. 2002 Nov;134(5):720-7
12429249
Hum Mol Genet. 1996 Sep;5(9):1229-35
8872461
Hum Mutat. 1998;Suppl 1:S114-6
9452059
Mol Cell. 2002 Dec;10(6):1453-65
12504019
Nat Genet. 2003 Jun;34(2):125-6
12776110
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10649-54
9724758
J Med Genet. 2004 Jan;41(1):e1
14729841
Nat Genet. 2003 Oct;35(2):190-4
14517543
Am J Hum Genet. 1995 Nov;57(5):1028-36
7485151
Hum Mol Genet. 2003 Jul 15;12(14):1725-35
12837695
Am J Med Genet. 1997 Dec 19;73(3):247-50
9415678
Nat Genet. 2003 Jun;34(2):157-65
12730694
Nat Genet. 1993 Jun;4(2):170-4
8348155
Hum Mutat. 1998;Suppl 1:S112-3
9452058
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6624-7
1677770
J Med Genet. 1999 Sep;36(9):708-10
10507730
Am J Hum Genet. 2005 Apr;76(4):663-71
15717285
Am J Med Genet. 1983 May;15(1):3-28
6344634
J Med Genet. 1992 Apr;29(4):251-2
1583645
Cell. 1995 Feb 10;80(3):431-7
7859284
Am J Med Genet. 2001 Nov 1;103(4):339-41
11746016
Indian J Dermatol Venereol Leprol. 2003 Nov-Dec;69(6):423-4
17642958
J Med Genet. 2004 Apr;41(4):e47
15060123
J Biol Chem. 2003 Jan 3;278(1):117-23
12399468
Am J Med Genet. 1991 Oct 1;41(1):44-8
1683158
Am J Hum Genet. 2005 Jan;76(1):8-32
15549674
Nat Genet. 2000 Dec;26(4):490-4
11101852
Nature. 1994 Dec 8;372(6506):525-30
7990924
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7548-53
12032320
Hum Mol Genet. 2004 Jun 15;13(12):1213-8
15115764
Genome Res. 2004 Apr;14(4):700-7
15060013
Clin Genet. 1991 Jun;39(6):401-8
1677832
Genetics. 2004 Nov;168(3):1557-62
15579706
Hum Mol Genet. 1996 Oct;5(10):1625-30
8894698
Am J Med Genet. 1999 Dec 3;87(4):349-53
10588843
Am J Ophthalmol. 1979 Sep;88(3 Pt 1):432-49
114056
Genomics. 2001 Nov;78(1-2):73-82
11707075